+1 Recommend
1 collections
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Blue-on-Yellow Perimetry Using an Armaly Glaucoma Screening Program


      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The purpose of the present investigation was to determine whether blue-on-yellow (B/Y) perimetry using a screening program can detect early glaucomatous change before it is evident with standard white-on-white (W/W) screening tests. The subjects included 25 normal, 20 ocular-hypertensive and 27 early glaucomatous eyes. From our results, even in normal subjects, B/Y perimetry alone demonstrated abnormal points in the nasal field in 10 eyes (40%). The Armaly central screening program was thought to be superior to the Armaly full-field program, because the former has less probabilities to detect a false-positive scotoma in the nasal field than the latter. In glaucomatous eyes, more abnormal points were detected by B/Y perimetry than by W/W perimetry. The screening program of B/Y perimetry is more advantageous than conventional tests in detecting early glaucomatous visual field defects.

          Related collections

          Author and article information

          S. Karger AG
          April 1999
          22 January 1999
          : 213
          : 2
          : 71-75
          Departments of Ophthalmology, aKobe University School of Medicine and bRokko Island Hospital, Kobe, Japan
          27398 Ophthalmologica 1999;213:71–75
          © 1999 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Figures: 2, Tables: 5, References: 19, Pages: 5
          Original Paper · Travail original · Originalarbeit

          Vision sciences,Ophthalmology & Optometry,Pathology
          Armaly central field,Armaly full field,Glaucoma screening test,Blue-on-yellow perimetry


          Comment on this article